Loading the map…
Private limited company registered in Boston, classed under “Management consultancy activities other than financial management” and 1 other activity.
Headline figures
FY to May 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
What the numbers say
2 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2024 | 2025 |
|---|---|---|
| Profit after tax | — | |
| Turnover | ||
| Net assets | ||
| Cash | ||
| Employees |
Every figure for all 2 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2024 | 2025 |
|---|---|---|
| Current assets | ||
| Creditors due within a year | ||
| Net current assets | ||
| Creditors due after a year | ||
| Net assets | ||
| Ratios | ||
| Current ratioCurrent assets for every £1 owed within a year | ||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||
5 balance-sheet lines and 2 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Visu-Med do?
Private limited company registered in Boston, classed under “Management consultancy activities other than financial management” and 1 other activity.
›How much turnover does Visu-Med make?
Answered in the full report
›Is Visu-Med profitable?
Visu-Med's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Visu-Med?
Answered in the full report
›Where is Visu-Med based?
Its registered office is 13 Witham Gardens, Boston, PE21 8PP, in Boston.
›When was Visu-Med founded?
Visu-Med Ltd was incorporated on 30 May 2023.
›Is Visu-Med still trading?
The register lists Visu-Med Ltd as active.